Please cite this article as follows: Chandra S, Shashikumar P. Diode laser -a novel therapeutic approach in the treatment of chronic periodontitis in type 2 diabetes mellitus patients: a prospective randomized controlled clinical trial. J Lasers Med Sci. 2019;10(1) Abstract Introduction: Maturity-onset diabetes mellitus affecting the elderly population is marked by insulin resistance and decreased insulin production. The relationship between periodontitis and diabetes is bidirectional. Type 2 diabetic patients are more prone to chronic periodontitis (CP) and severe periodontitis affects the glycemic control in such patients. Recently, dental diode laser has become an effective tool in controlling CP. To date, very few studies have been conducted to check the efficacy of diode laser in control of periodontal destruction in type 2 diabetes mellitus (DM2) patients. Hence, the need of the study was to evaluate whether diode laser helps improvement of periodontal outcome and reduction in anaerobic bacteria in elderly diabetic patients with CP. Methods: Forty DM2 patients with CP were randomized into group A (control): scaling and root planing (SRP) only and group B (test): SRP followed by soft tissue dental diode laser (808 nm) application. Four patients (2 in each group) were lost during follow up. Clinical parameters, plaque samples and glycated hemoglobin levels were evaluated at both baseline and 90 days post-treatment. Results: Improvement in clinical, microbiological and glycemic parameters were noted in the group that received SRP as well as SRP + LANAP (laser-assisted new attachment procedure). The reductions in clinical parameters were statistically significant after 3 months (P < 0.001). The microbial analysis of plaque samples for Aggregatibacter actinomycetemcomitans (Aa) and Porphyromonas gingivalis (Pg) decreased significantly after 3 months in group B than in group A. Glycated hemoglobin level (HbA1c) decreased significantly after 90 days in both the groups (P < 0.001) with more reduction in the SRP+LANAP group (6.49%) in comparison to SRP alone (16.25% vs. 9.76%). However, on the intergroup comparison, the difference in HbA1c reduction was nonsignificant.
Introduction
Chronic periodontitis (CP) is a multifactorial disease caused by various periodontopathogenic bacteria that results in the destruction of the tooth-supporting tissues i.e. periodontal tissue. 1 Diabetes mellitus is a chronic metabolic disorder of the pancreas that results in marked hyperglycemia due to insulin resistance and decreased production of insulin by the pancreas. 2, 3 Non-insulin dependent diabetes mellitus (NIDDM) also known as type 2 diabetes mellitus (DM2) is more common in the elderly population. Periodontitis is considered a sixth complication in diabetic patients. The relationship between Periodontitis and NIDDM is bidirectional. NIDDM predisposes an individual to the risk of developing CP, and severe periodontitis affects glycemic control in diabetic patients. 4 Few meta-analyses studies have confirmed that HbA1c reduction of around 0.4% can be anticipated following effective periodontal therapy. 5 The primary etiological factor for the existence of periodontitis is pathogenic microorganisms within the Journal of Lasers in Medical Sciences Volume 10, Number 1, Winter 2019 57 Diode Laser -A Novel Therapeutic Approach subgingival biofilm. Specific periodontopathogenic bacterial species and their virulence factors have been recognized as etiological agents and they affect the rate of progression of the disease. Hence, they act as indicators for progression of periodontal breakdown. 6 Today about a dozen oral microorganisms are classified as periodontal pathogens. Foremost among these are gram-negative organisms including Aggregatibacter actinomycetemcomitans (Aa) and Porphyromonas gingivalis (Pg) . 7 The elimination of subgingival microorganism and regeneration of lost tissue is considered as the most important goal of periodontal therapy. Successful periodontal therapy is determined by control of destructive periodontal pathogens along with a shift in the microbial flora towards one that is typically present in health. [8] [9] [10] This elimination of the pathogenic subgingival microbiota can be achieved by nonsurgical periodontal therapy which is considered as the gold standard for a plaque as well as microbial elimination. [10] [11] [12] However, previous studies have shown that nonsurgical periodontal therapy alone may fail to completely eliminate the pathogenic subgingival microbiota because of limited access to the instruments, as a result, this may lead to persistent periodontopathogens. 10, [13] [14] [15] These limitations of mechanical therapy have led to a shift to other adjunctive measures such as the use of antimicrobial therapy. The spread of localized inflammation which is closely associated with the destruction of the supporting periodontal tissue is promoted by the microbial colonization, especially the gram-negative anaerobic bacteria in deep inaccessible areas such as furcation areas and root concavities. This justifies the need for the bacterial elimination from periodontal pockets. 16 Mechanical methods such as scaling and root planing (SRP) are not sufficient for the complete bacterial elimination. 17, 18 Systemic antibiotics have been employed in cases which are nonresponsive to conventional periodontal treatments in spite of the known systemic side effects of antibiotics and the development of antibiotic resistance. 1, 19 Dental diode laser system has become an effective tool when used along with conventional periodontal therapy resulting in significant bacterial reduction which makes the adjunctive use of antibiotics almost unnecessary. 20 Lasers have been used in periodontal therapy since long for subgingival curettage, gingivectomy, frenectomy, removal of granulation tissue, during flap surgery, osseous recontouring, implant maintenance and management of peri-implantitis. The antimicrobial efficacy of diode laser has been proven in a number of studies. 7 Due to its exceptional ease of use and affordability as well as action on various pigmented periodontal pathogens the diode laser has become an integral tool in the dental armamentarium. 21 It is well absorbed by various chromophores present in diseased periodontal tissues such as melanin and hemoglobin. 22 These evidence in the dental literature states diode laser is a useful adjunct to nonsurgical periodontal therapy in producing improved results. 23 Although several studies have shown the efficacy of soft tissue diode laser therapy over SRP alone in the treatment of CP, very few studies were done in NIDDM patients who are frequently affected by CP due to bidirectional relationship and to assess whether laser-assisted new attachment procedure (LANAP) has additional systemic beneficial effect on glycemic control, improvement in overall clinical outcome and the reduction in periodontal microbiology. • Consenting patients who were cooperative and able to come for regular follow up.
Methods

Exclusion Criteria
• Pregnant/lactating women.
• Patients who were on antibiotic therapy in the previous six months.
• Patients who had undertaken any periodontal therapy in past 6 months.
• Smoking.
• Alcoholism.
Sample Size By purposive sampling, 40 patients were selected who fulfilled the inclusion criteria. Four patients (2 in test and 2 in control) were lost during follow-up. After baseline examination, 36 patients were assigned randomly to test and control group of 18 patients each (Figure 1 ).
Study Design
This was a parallel design, randomized, single-blind, and controlled clinical trial of 3 months duration. The study was conducted to compare and evaluate Diode Laser therapy as an adjunct to SRP in NIDDM patients with CP.
• Group A (Control group): SRP followed by irrigation with normal saline.
• Group B (Test group): SRP followed by diode laser application (laser assisted new attachment procedure, LANAP) and irrigation with normal saline.
Randomization
The randomization of 36 patients was done as follows. 36 type 2 diabetes and CP reported to the investigator of the study. The investigator who was blind to the study protocol then randomly assigned 36 patients into test and control group by sequentially numbered sealed opaque envelopes. The operator then according to the treatment assigned in the sealed envelope treated the patients either by SRP alone or SRP+LANAP and then recalled the patients after 3 months for follow-up. All the patients who had participated in the study fulfilling the inclusion criteria had to fill an informed consent prior to the study.
Study Protocol
• In the first visit oral hygiene instructions were given.
• Patients were then recalled after 7 days for baseline blood investigation (HbA1c), a collection of subgingival plaque samples and measurements of clinical parameters followed by nonsurgical periodontal therapy in control group and SRP followed by LANAP in the test group.
• Subgingival plaque samples were sent for microbiological analysis.
• Laser application was done with the help of an active diode laser (Mikro ® Sunny 808 nm diode laser). A wavelength 808 nm and a power setting of 1.5 W-1.8 W were used in continuous, contact mode with a thin flexible fiber-optic cable (320 nm). The fiber optic cable was introduced into the periodontal pocket with the laser beam directed towards the soft tissue of the pocket wall and moved in an apico-coronal direction, with a sweeping motion. The depth of the periodontal pocket in millimeters corresponds to the • CAL -using a UNC-15 probe from a fixed reference point on the crown to the base of the pocket.
• Probing depth (PD) -using a UNC-15 probe taken from the margin of the gingiva to the base of the pocket.
Microbiological Analysis
The collection of plaque sample was done in the Department of Periodontology, JSS Dental College, and Hospital, Mysuru. Collection of subgingival plaque samples was done by the same operator to standardize the sampling procedure. Before sampling, the adjacent teeth were isolated with cotton rolls. To standardize site selection and adequate sample volume, plaque sample was collected from all the quadrants and pooled in reduced transport fluid (RTF) medium for microbiological analysis. Plaque samples contaminated with blood and saliva were discarded. The samples were then immediately transferred for microbiological culturing of Aa and Pg which were then separately vortexed and inoculated in anaerobic jar according to the requirement for culturing
• Pregnant/lactating women. control group of 18 patients each (Figure 1 ). 
Statistical Analysis
The values obtained from the clinical, microbiological and hematological data were subjected to following statistical analysis:
• Descriptive statistics -mean and standard deviation.
• Paired samples "t-test" for within group comparison.
• Independent-samples t test for comparison between 2 groups. The data obtained were processed using statistical software (SPSS 22 for Windows).
Results
The study outline is explained in Figure 1 . The demographic data of the patients at baseline are illustrated in Table 1 .
Clinical Parameters There was a statistically significant improvement in clinical parameters from baseline to 3 months postoperatively (P < 0.001) ( Table 2) . The results are displayed in boxplots diagrams in Figure 2 .
HbA1c(%)
The results of HbA1c values are depicted in Figure  3 . The values of HbA1c in the test site decreased from 8.122± 1.26 at baseline to 6.833 ± 0.651 at 3 months and in the control, site decreased from 7.994 ± 1.27 at baseline to 7.217± 0.793 at 3 months. There was 6.49% more reduction in HbA1c levels in the SRP+LANAP group compared to SRP alone (16.25% vs. 9.76%) but on intergroup comparison the difference in HbA1c reduction was nonsignificant. The changes in HbA1c(%) are shown in Table 3 .
Microbiological Analysis
The collection of subgingival plaque samples for the culturing of anaerobic bacteria was done at baseline and 3 months postoperatively. The results in CFU/mL of Aa and Pg are shown in (Figure 4 ). Figure 4 ).
Discussion
The current study shows a better reduction of HbA1c levels, in laser treated group (16.25%) than in SRP treated group (9.76%) after 3 months but this reduction was not statistically significant on the intergroup comparison from baseline to 3 months. The values of HbA1c at 3 months decreased from 7.994± 1.27 at baseline to 7.217± 0.793 at 3 months. There was 6.49% more reduction in HbA1c levels in the SRP+LANAP group compared to SRP alone (16.25% vs. 9.76%) but on intergroup comparison the difference in HbA1c reduction was nonsignificant. The changes in HbA1c(%) are shown in Table 3 , Figure 3 . 
Microbiological Analysis
The collection of subgingival plaque samples for the culturing of anaerobic bacteria was done at baseline and 3 months postoperatively. The results in CFU/ml of Aa and Pg are shown in (Fig. 4) . postoperatively decreased from 8.12% to 6.8% in the test group (SRP+LANAP) and 7.9% to 7.2% in control group (SRP). In the present study, the lowering of HbA1c levels after nonsurgical periodontal therapy was in accordance with previously reported studies. [25] [26] [27] [28] [29] Previous studies had linked obesity and smoking as Table 1 . Table 2 ). The results are displayed in boxplots diagrams in Figure 2. A B
Colony count of Aa (CFU/ml)
Clinical Parameters
There was a statistically significant improvement in clinical parameters from baseline to 3 months postoperatively (P<0.001) (
There was a statistically significant improvement in clinical parameters from baseline to 3 months postoperatively (P<0.001) ( Table 2 ). The results are displayed in boxplots diagrams in Figure 2 . Sig. value 0.000* 0.000* Abbreviations: PI, plaque index; GI: gingival index: PD: probing depth; CAL: clinical attachment level; SRP: scaling and root planning; LANAP: Laser-assisted new attachment procedure; (*) statistically significant
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The results of HbA1c values are depicted in Figure 4 Sig. value 0.000* 0.000* Abbreviations: PI, plaque index; GI: gingival index: PD: probing depth; CAL: clinical attachment level; SRP: scaling and root planning; LANAP: Laser-assisted new attachment procedure; (*) statistically significant
The results of HbA1c values are depicted in Figure 4 . The values of HbA1c in the test site decreased from 8.122± 1.26 at baseline to 6.833± 0.651 at 3 months and in the control, site confounding factors to diabetes mellitus and HbA1c control in patients with CP. 27 In the present study patients had confirmed diagnosis of DM2, with a mean BMI <24 kg/m 2 , and were nonsmokers, which positively helped in assessing the bidirectional relationship of DM2 and CP. The outcome of the current study was similar with those of two recent investigations that examined the effect of PDT alone and in combination with SRP in patients receiving initial and supportive periodontal therapy. Because PDT had no reported systemic effect, there was no reason to assume that it would improve HbA1c levels. 30, 31 This is in contradiction to a recent study by Koçak and Sağlam which showed SRP+ Diode laser group showed statistically significant improvement in glycemic control (HbA1c) than in SRP group in patients with DM2 and CP. 32 The present study showed improvement in all clinical parameters (PI, GI, PD, CAL) from baseline to 3 months in SRP and SRP+LANAP group which was statistically significant. The value of plaque index reduced from 2.31 at baseline to 1.56 at 3 months in control and from 2.45 to 1.26 in the test group. This observation is in accordance with a study done by Berakdar et al. 33 The value of GI score reduced from 2.23 at baseline to 1.55 at 3 months after therapy in control and from 2.19 to 1.04 in the test group. This is in accordance with a study by Fallah where after 6 weeks there is compelling evidence of improvement in gingival. 34 The mean reduction of PD and CAL from baseline to 3 months in the present study were similar with those obtained by other studies. 7, [35] [36] [37] [38] A study was done by Obradovic et al where laser as an adjunct to SRP showed significant improvement in gingival inflammation compared to SRP alone in NIDDM patients. 39 Another histologic study by Obradovic et al, showed a faster healing response when SRP was combined with DL in NIDDM patients. 40 In a study by Yukna et al laser as an adjunct to SRP resulted in significant reduction of PD with a gain in CAL. 41 This reduction in PD can be explained due to better pocket epithelial lining removal by soft tissue diode laser leading to connective tissue attachment directly to root surface favoring regeneration as reported by Kreisler et al. 36 A similar study conducted on animals by Romanos et al. 42 showed better removal of pocket epithelial lining in DL+SRP group compared to conventional hand instruments. Hence, the abovementioned studies suggest that a better response in clinical parameters can be achieved when diode laser is used as an adjunct to conventional SRP. The present study showed a significant reduction in colony count (CFU/mL) of Aa and Pg from base line to 3 months follow-up in both the groups. The colony count of Aa in control group decreased from 104. 44 Thus, the present study shows that diode laser application is effective in reducing inflammation due to the antimicrobial property of laser. A classic study by Pick and Colvard et al in 1998 on the treatment of periodontal pockets using 810 nm diode lasers showed immediate structural damage of gram-negative bacteria and a marked reduction of periodontopathogens namely Aa and Pa. 7, 44 Diode laser is effective not only in the elimination of bacteria from the periodontal pocket but also the complete removal of bacterial toxins from root cementum. 45 Another study by Lin et al showed marked reduction of Aa and prevent further recolonization for up to 28 days using diode lasers. 46 
Conclusion
The present study showed statistically significant improvement in clinical and microbiological parameters in the test than in control group from baseline to 3 months. Thus we can conclude that the use of diode laser therapy after SRP is more effective than SRP alone in the overall improvement of clinical and microbiological parameters. Also, the adjunctive use of soft tissue diode laser resulted in better improvement in HbA1c in NIDDM patients than SRP alone after 3 months. The percentage decrease in HbA1c was (16.25%) in test versus (9.76 %) in control but the difference between the groups was not statistically significant. This suggests the need for further long-term randomized controlled clinical trials with larger sample size before generalizing that diode laser therapy results in improved glycemic control in maturity onset diabetes mellitus patients with CP.
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